These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: a preliminary analysis. Smith AD; Shah SN; Rini BI; Lieber ML; Remer EM Urol Oncol; 2013 Oct; 31(7):1283-91. PubMed ID: 21956044 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919 [TBL] [Abstract][Full Text] [Related]
31. Stage T3a renal cell carcinoma: staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion. Sokhi HK; Mok WY; Patel U Br J Radiol; 2015 Jan; 88(1045):20140504. PubMed ID: 25410425 [TBL] [Abstract][Full Text] [Related]
32. Impact of renal vein invasion and fat invasion in pT3a renal cell carcinoma. da Costa WH; Moniz RR; da Cunha IW; Fonseca FP; Guimaraes GC; de Cássio Zequi S BJU Int; 2012 Feb; 109(4):544-8. PubMed ID: 21711437 [TBL] [Abstract][Full Text] [Related]
33. Accuracy of multidetector CT scans in staging of renal carcinoma. Nazim SM; Ather MH; Hafeez K; Salam B Int J Surg; 2011; 9(1):86-90. PubMed ID: 20937417 [TBL] [Abstract][Full Text] [Related]
34. Baseline perfusion CT parameters as potential biomarkers in predicting long-term prognosis of localized clear cell renal cell carcinoma. Wang Y; Cui L; Zhang J; Zhang L; Zhang J; Zhao X; Chen Y Abdom Radiol (NY); 2019 Oct; 44(10):3370-3376. PubMed ID: 31399787 [TBL] [Abstract][Full Text] [Related]
35. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival. Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539 [TBL] [Abstract][Full Text] [Related]
36. Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours. Karlo CA; Kou L; Di Paolo PL; Kattan MW; Motzer RJ; Russo P; Tickoo SK; Akin O; Hricak H Eur J Cancer; 2016 May; 59():57-64. PubMed ID: 27016623 [TBL] [Abstract][Full Text] [Related]
37. Relationship of pathologic factors to efficacy of sorafenib treatment in patients with metastatic clear cell renal cell carcinoma. Araki H; Tsuzuki T; Kimura T; Tanaka K; Yamada S; Sassa N; Yoshino Y; Hattori R; Gotoh M Am J Clin Pathol; 2015 Apr; 143(4):492-9. PubMed ID: 25780000 [TBL] [Abstract][Full Text] [Related]
38. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma. Ding J; Xing Z; Jiang Z; Chen J; Pan L; Qiu J; Xing W Eur J Radiol; 2018 Jun; 103():51-56. PubMed ID: 29803385 [TBL] [Abstract][Full Text] [Related]
39. CT of renal cell carcinoma: assessment of collecting system invasion. Karlo CA; Di Paolo PL; Hricak H; Tickoo SK; Russo P; Akin O AJR Am J Roentgenol; 2013 Dec; 201(6):W821-7. PubMed ID: 24261389 [TBL] [Abstract][Full Text] [Related]
40. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]